Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Curigliano

Showing results (1-10 of 750) with videos related to

Pageof 75
Sort By:
Breast Care (Basel, Switzerland)|August 9, 2017
How to Achieve Optimal Care in Early Breast Cancer with 'Less' or 'More' TreatmentGiuseppe Curigliano
Handbook of Experimental Pharmacology|November 9, 2018
Cancer Evolution as the New Frontier of Precision MedicineGiuseppe Curigliano
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 24, 2018
Inflammatory breast cancer and chest wall disease: The oncologist perspectiveGiuseppe Curigliano
Breast (Edinburgh, Scotland)|October 22, 2011
Immunity and autoimmunity: revising the concepts of response to breast cancerGiuseppe Curigliano
Cancer Treatment Reviews|July 19, 2011
New drugs for breast cancer subtypes: targeting driver pathways to overcome resistanceGiuseppe Curigliano
Current Opinion in Oncology|October 4, 2014
'Tu quoque Brute fili mihi!' (Julius Caesar, Ides of March, 44 BC): role of tumor microenvironment and immune system in breast cancer progressionGiuseppe Curigliano
Breast (Edinburgh, Scotland)|September 8, 2016
Being more precise in assessing the value of precision medicine in breast cancerGiuseppe Curigliano
The Oncologist|April 17, 2020
How to Guarantee the Best of Care to Patients with Cancer During the COVID-19 Epidemic: The Italian ExperienceGiuseppe Curigliano
Cancer Cell|July 26, 2020
Cancer Patients and Risk of Mortality for COVID-19Giuseppe Curigliano
Nature Reviews. Clinical Oncology|November 25, 2020
CDK4/6 inhibitors for HR<sup>+</sup>HER2<sup>-</sup> early stage breast cancer - when to escalate treatment?Giuseppe Curigliano
Pageof 75

Showing results (1-10 of 750) with videos related to

Sort By:
Pageof 75
Breast Care (Basel, Switzerland)|August 9, 2017
How to Achieve Optimal Care in Early Breast Cancer with 'Less' or 'More' TreatmentGiuseppe Curigliano
Handbook of Experimental Pharmacology|November 9, 2018
Cancer Evolution as the New Frontier of Precision MedicineGiuseppe Curigliano
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 24, 2018
Inflammatory breast cancer and chest wall disease: The oncologist perspectiveGiuseppe Curigliano
Breast (Edinburgh, Scotland)|October 22, 2011
Immunity and autoimmunity: revising the concepts of response to breast cancerGiuseppe Curigliano
Cancer Treatment Reviews|July 19, 2011
New drugs for breast cancer subtypes: targeting driver pathways to overcome resistanceGiuseppe Curigliano
Current Opinion in Oncology|October 4, 2014
'Tu quoque Brute fili mihi!' (Julius Caesar, Ides of March, 44 BC): role of tumor microenvironment and immune system in breast cancer progressionGiuseppe Curigliano
Breast (Edinburgh, Scotland)|September 8, 2016
Being more precise in assessing the value of precision medicine in breast cancerGiuseppe Curigliano
The Oncologist|April 17, 2020
How to Guarantee the Best of Care to Patients with Cancer During the COVID-19 Epidemic: The Italian ExperienceGiuseppe Curigliano
Cancer Cell|July 26, 2020
Cancer Patients and Risk of Mortality for COVID-19Giuseppe Curigliano
Nature Reviews. Clinical Oncology|November 25, 2020
CDK4/6 inhibitors for HR<sup>+</sup>HER2<sup>-</sup> early stage breast cancer - when to escalate treatment?Giuseppe Curigliano
Pageof 75